Second Quarter Outlook For Biotech Stocks - Seeking Alpha
About 67% of PT Klinko's investor base is looking to short. The analysis of current outlook of investing in PT Klinko Karya suggests that many traders are alarmed regarding PT Klinko's prospects. PT Klinko's investing sentiment shows overall attitude of investors towards PT Klinko Karya.
KLIN |
Second Quarter Outlook For Biotech Stocks Seeking Alpha
Read at news.google.com
 |
PT Klinko Fundamental Analysis
We analyze PT Klinko's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Klinko using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Klinko based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
PT Klinko is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
PT Klinko Karya Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PT Klinko stock to make a market-neutral strategy. Peer analysis of PT Klinko could also be used in its relative valuation, which is a method of valuing PT Klinko by comparing valuation metrics with similar companies.
Peers
PT Klinko Related Equities
| KKES | PT Kusuma | 4.35 | ||||
| LFLO | Imago Mulia | 2.91 | ||||
| KRYA | Bangun Karya | 0.00 | ||||
| MEDS | PT Hetzer | 0.00 | ||||
| TOOL | PT Rohartindo | 1.96 |
Other Information on Investing in KLIN Stock
PT Klinko financial ratios help investors to determine whether KLIN Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KLIN with respect to the benefits of owning PT Klinko security.